Age and fast initial response predict omalizumab retreatment in chronic urticaria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Age and fast initial response predict omalizumab retreatment in chronic urticaria

Published:2023-11 Issue:11 Volume:11 Page:3556-3558.e1
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Meertens Michelle A.J.,Luijf Teddy,van Lindonk Esmee A.M.,Soegiharto Reineke,Assil Salma,Alizadeh Aghdam Mehran,Kentie Petra A.,Knulst Andre C.,van Doorn Martijn B.A.,Röckmann Heike

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference6 articles.

1. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria;Zuberbier;Allergy,2022

2. Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria;Niemeyer-van der Kolk;J Allergy Clin Immunol,2018

3. Effective omalizumab interval prolongation in the treatment of chronic urticaria;Aghdam;J Allergy Clin Immunol Pract,2020

4. Omalizumab retreatment in patients with chronic spontaneous urticaria: a systematic review of published evidence;Tonacci;Eur Ann Allergy Clin Immunol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the Speed of Response to Omalizumab in Chronic Spontaneous Urticaria;International Archives of Allergy and Immunology;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP